ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2)
Ghosal, Nirajan ; Tapadar, Poulami ; Biswas, Divisha ; Pal, Ranjana
Molecular biology reports, 2024-12, Vol.51 (1), p.671-671, Article 671 [Revista revisada por pares]Dordrecht: Springer Netherlands
Texto completo disponible